youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
MEDP:NASDAQ
Medpace Holdings Inc
$623.54
arrow_upward
+0.63%(+3.88) 1D
Oct 20, 3:09:11 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MEDP...
Open
$626.64
High
$637.15
Low
$613.13
Mkt. cap
17.40B
Avg. vol.
253.70K
Volume
238.01K
P/E ratio
36.58
52-wk high
$677.90
52-wk low
$373.00
EPS
$17.05
Beta
1.18
Shares outstanding
27.91M
No. of employees
6K
Open
$626.64
High
$637.15
Low
$613.13
Mkt. cap
17.40B
Avg. vol.
253.70K
Volume
238.01K
P/E ratio
36.58
52-wk high
$677.90
52-wk low
$373.00
EPS
$17.05
Beta
1.18
Shares outstanding
27.91M
No. of employees
6K
News stories
From web sources and news partners
The National Law Review
·
1 hour ago
Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz
ad-hoc-news.de
·
1 hour ago
Medpace schedules October 21 results: what it means for Medpace Holdings stock
TradingView
·
16 hours ago
What To Expect From Medpace’s (MEDP) Q3 Earnings
Profile
Medpace Holdings, Inc. is a global clinical research organization based in Cincinnati, Ohio, employing approximately 6,500 people. Operating under a full-service model, the company also offers global central laboratory, imaging and ECG core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
The company started trading stock as a public firm in 2016. Wikipedia
About Medpace Holdings Inc
CEOAugust J. Troendle
Employees6.5K
Founded1992
HeadquartersCincinnati, Ohio, United States
SectorHealth care
Websitemedpace.com